- Jefferson Health sues Independence Blue Cross over nearly $100M in disputed payments
- 240 community hospital CEOs to know | 2026
- 4 behavioral health data breaches making headlines
- 17 recent hospital, health system president exits
- 5 federal behavioral health bills for leaders to watch
- HHS appeals decision vacating provisions of 2025 ACA marketplace rule
- Imagen Dental Partners adds Seattle practice
- Texas dental practice suffers data breach
- Health systems alter approaches to workforce housing
- ACA fallout hits for-profit health systems harder than expected
- 25 new behavioral health study findings to know
- Rural hospitals build scale to stay independent: Commonwealth Fund
- Lunch, low acuity and ‘family’: How ASCs beat the CRNA cost crunch
- HCA’s $1.2B ACA hit raises red flag for nonprofit health systems
- Where AI is delivering the biggest supply chain wins
- Northwell’s Lenox Hill Hospital Brain Tumor Center Gala raises $1.6M
- Florida dental office remains closed amid patient death investigation
- Lyon College dental school names inaugural medical director for pediatric program
- A massive month for ASC policy: 5 key updates
- 130+ DSO affiliations so far in 2026: State-by-state breakdown
- AHA releases SUD treatment toolkits
- 8 DSOs making headlines
- California unveils $109M for behavioral health supportive housing
- Idaho physician to pay $1.25M for Medicare, telemedicine fraud scheme
- Connecticut enacts sweeping CON reforms: 10 things to know
- The 1st physician specialty to top $600K
- 38% of teens use a substance by age 16: 5 study notes
- Why it’s time to ‘jettison’ Stark law
- Allina Health to open 620,000-square-foot surgery center
- Tenet Healthcare shrugs off ACA headwinds with sweeping Q2 outperformance, boosts 2026 guidance
- FDA Advisers Dismiss Safety Warnings, Back Four Peptide Treatments
- Frequent Marijuana Use Linked To Higher Stress Hormone Levels
- What's behind Aetna's investments to build provider trust
- New university initiative offers screening, referrals for endometriosis
- Peptide adcomm Day 2: Emideltide voted down in panel's 1st pushback
- HCA Healthcare's H1 ACA volume dropoffs 'almost one for one' shifted to uninsurance
- Novo escalates Lilly false advertising suit with planned bid to halt comparative ads
- Industry Voices—The new model for rural healthcare is already taking shape
- Amgen hands in data package in hopes of FDA hearing for Tavneos defense
- Another setback for Ipsen's Albireo portfolio as Bylvay flunks phase 3 trial
- Back Pain? Try Swimming, Study Says
- Ozempic Cuts Down Calorie Intake For At Least A Year, Even If Hunger Returns, Trial Finds
- Money Problems Might Make Your Brain Old Before Its Time, Study Suggests
- GSK’s first lung cancer approval, a new IPO path and more
- Merck stages expanded access to monthly HIV PrEP pill ahead of approval
- Black MS Patients Dying Younger Than White Ones, Study Finds
- Public Health Improvements Stall Amid Trump's DEI Crackdown
- To Afford Aging in Place, Older Adults Turn to ‘Golden Girls’ Housing
- Watch: GOP Senator Says Trump’s Tariffs Could Mean Safer Drugs — For a Price
- ‘The Child Is Terrified’: Doctors on the Front Lines of a Measles Comeback Speak Out
- Gastroenterologists flag clinical remission and its durability as unmet needs in IBD care: survey
- OpenAI makes Health in ChatGPT widely available, moving deeper into consumer health
- Many U.S. Schools Unprepared To Help Concussed Students Return To The Classroom
- Oral surgery platform buys back ownership stake from private equity firm
- Stamford Health opens EmPATH unit with follow-up care
- What will it take to truly fix anesthesia?
- 5 forces reshaping physician compensation in 2026
- Cardiologists’ pay averaged $575K in 2025, yet half feel underpaid: 10 stats to know
- New York unveils dashboard tracking mental health investments
- PDS Health-anchored retail pad in South Carolina sold for $3.7M
- 15 behavioral health services, facility closures | 2026
- Growth in a year the industry slowed: what Elevate Dental Partners is doing differently
- Philadelphia dentist whose patients were urged to get tested for HIV, hepatitis to reopen practice
- The unlicensed therapist 8 million kids are seeing
- Fierce Pharma Asia—Trump’s generic drug tariffs; Samsung Bio’s $1.8B acquisition; An unusual IPO
- New CMS data spotlight continued rise in No Surprises Act disputes
- Weekly Rundown: FDA names Dexcom as first TEMPO participant; Ardent Health tops 1M patient visits with ambient AI
- UPDATE: Peptides favored on 1st day of closely watched FDA compounding adcomm
- Nearly 1.6 Million Dozen Eggs Pulled From Shelves Over Salmonella Concerns
- Molina Healthcare plans more marketplace exits as ACA segment falters
- Organized Sports Help Enhance Motor Skills In Children With Autism
- Teal Health, UC Davis team up to expand HPV screening access
- D.C. appeals court sides with HHS in 340B drug discount program rebate challenge
- Roche defends 6B franc Vabysmo peak sales target despite another quarterly miss
- BeOne jumps aboard onshoring train with $300M to add small molecule production in US
- People Living Longer, But Spending More Years With Illness And Disability
- Exercise Underwhelms As A Hip Arthritis Treatment, Review Concludes
- Tongue Pacemaker Might Improve Sleep Apnea Patients' Health
- Poll: Costs Are Top Health Care Issue For Midterm Voters, But Fraud Tops GOP List
- Listen to the Latest ‘KFF Health News Minute’
- Public Health Improvements Stall Amid Trump’s DEI Crackdown
- A Death Revives Concerns About Police Brutality Six Years After National Reckoning
- FDA rebukes 2 Indian API plants over data controls, sanitation issues
- Australian biopharma Clinuvel to shed up to 20% of workforce in move to US
- J&J’s bispecific combo slashes myeloma progression risk by 89% in phase 3 trial
- ARS Pharma drafts NFL legend Drew Brees in allergy awareness push
- Teladoc Health unveils new virtual care model for employers, health plans that ties payment to results
- Anterior, Stellarus enter strategic partnership to speed up AI-driven prior authorizations
- Amid ACA subsidy fallout, half of Community Health Systems' Q2 volume gains were uninsured patients
- CMS appeals court decision behind 2026 MA star ratings recalculations
- Boulder Care awarded NIH grant to provide SUD care in complex settings
- Prosper Medical banks $16M to scale AI-driven concierge care platform
- CMS proposed rule lays groundwork for more OBBBA provider tax cutbacks
- Measles Cases Set 35-Year US Record With Months To Go In 2026
- Taylor Farms Faces Cyclospora Outbreak, Recalls And Political Questions
- GSK secures first lung cancer approval as FDA clears Jideytro in quick payoff from Nuvalent deal
- Cigna expands AI-powered care management programs for members
- Visana revamps well-woman visit to comprehensively address symptoms
- Headstands and Summervaults: A Statement on Crypto Vaults and Lending Strategies
- What to Expect at PODD 2026
- Candid Health secures $120M series D as investment in AI-powered RCM ramps up
- GLP-1 Use Surges Among Young People With Obesity
- FDA calls out Sanofi emails for giving 'misleading impression' of Beyfortus use in RSV
- Look out Ionis, here comes Arrowhead with promising hypertriglyceridemia data
- Trump floats countdown to 200% tariffs on generic drugs imported to US
- Summit Therapeutics updates ivonescimab survival data ahead of FDA decision date
- How Does ADHD Affect Athletes' Concussion Risk?
- 1 In 4 Americans Stuck In Jobs For Health Insurance, Survey Finds
- TV Does Indeed Rot Your Brain, Study Says
- Tick-Borne Meat Allergy: Many Carry Alpha-Gal Antibodies Without Symptoms
- Agencies In New York And Beyond Pass The Buck On Opioid Cash Oversight
- American Scientists See Prosecutions as Part of Federal Campaign Against Them
- Trump’s Personnel Agency Says It Will Remove Some Identifying Info as It Sweeps Up Medical Records
- Biotech industry leaders file brief backing FDA against ‘malicious’ mifepristone challenge
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Seeking Public Comment on Seeking Public Capital: Remarks Before the Small Business Capital Formation Advisory Committee
- Remarks to the Small Business Capital Formation Advisory Committee
- Cannabis Drinks Sold Next To Soda Are Sending Kids To The ER, Doctors Say
- Coffee May Lower Your Heart Disease Risk, But How Much Is Safe?
- More Than Half Of US Adults Should Be Offered Statins, Study Says
- Gait Training Can Help Knee Arthritis
- The Best Surgery For Pelvic Organ Prolapse?
- Doctors 'Cringe' At Possibility Of Documenting Which Medicaid Enrollees Are Too Sick to Work
- Compounded Ozempic, Zepbound Still Widely Available Despite End Of Drug Shortages
- A Deloitte-Run System Denied Medicaid Benefits for Michigan’s Disabled. Now Trump’s Law Piles On.
- Leadership Vacuum: Agencies in New York and Beyond Pass the Buck on Opioid Cash Oversight
- FDA: Iceberg Lettuce Recall Stands After False Positive For Cyclospora
- Why Do So Many Women Miss The Signs Of Perimenopause?
- Virtual Therapy Sessions Improve Lives Of Kids With Lupus
- More Evidence Links Sleep Apnea To Dementia And Memory Loss
- Study Links GLP-1 Medications To Rare Vision Issue
- Gut Bacteria May Hold Key To Preventing Severe Peanut Allergies
- Trump's CDC Nominee Praises Vaccines, Without Vowing Independence From RFK Jr.
- CDC Warns Of Parasite Outbreak Tied To Taco Bell Lettuce In 5 States
- The Best Vegetables For Your Heart May Depend On Your Sex
- One Type Of ADHD Med May Affect Kids' Weight
- Poll: Many Older Americans Unaware Of 988 Suicide Help Line
- ‘Substantially better than before’: Why India has golden opportunity to build on innovative R&D wins
- Statement on Regulation E-Delivery
- Paper Taper: Statement on Proposed Regulation E-Delivery
- Statement on Proposed Regulation E-Delivery
- Remarks before the American-Hellenic Chamber of Commerce
- Remarks at the Society for Corporate Governance Conference
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- Statement on the 2026 Regulatory Agenda
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
Michigan healthcare freedom community forum
We've heard enough whiz-bang health reform ideas out of Washington, D.C. to earn the right of cynics everywhere to yawn and go do something effective like washing dishes.
Here Real Clear Policy delivers a Congressional assessment with enough substance, I'm tempted to actually follow it.
We'll see.
The Right Rx on Health Policy: a Strong House Performance
After enacting a pro-patient, pro-consumer health care agenda that could expand personal choices and lower costs, House Speaker Kevin McCarthy (R-CA) and his leadership team deserve credit. From expanding access to affordable health coverage for small businesses to ensuring price transparency for medical services and requiring Medicare to pay the same for certain procedures, whether they are delivered in a hospital setting or a doctor’s office, the Speaker’s targeted approach is starting to bear fruit.
The recently enacted Choice Arrangement Act (H.R. 3799), sponsored by Rep. Kevin Hern (R-OK), is a prime example. Heading to the Senate after being passed by a vote of 220 to 209, Rep. Hern’s bill directly addresses the problems of small businesses and their workers who have no options if they cannot afford the current cost of group employment coverage.
Under the bill, small employers would be able to band together—whether they are in the same industry or not—to create an “association health plan” and a large insurance pool that would empower employers to negotiate lower premiums and out-of- pocket costs for their employees. It would also enable them to customize their benefit offerings, which would reduce employee premium costs.
Rep. Hern’s bill also allows employers to provide individual coverage health reimbursement arrangements (ICHRAs) for their workers. Under these arrangements, employers can make tax-free contributions to special accounts that workers can then use to buy individual health insurance with tax-free premiums. That means that workers and their families would be able to enroll in the kind of health plans that they want, but without companies imposing lifetime caps or denying people coverage for preventive medical services.
Overall, the bill expands private coverage options for workers and businesses—something that the ACA and other government-run health programs fail to do. Perhaps that’s why the National Federation of Independent Business (NFIB), representing small businesses, strongly supports the bill. It certainly helps explain why the Biden administration strongly opposes it.
Meanwhile, in a refreshing break from intense partisan polarization, Rep. Cathy McMorris Rogers (R-WA), chair of the House Energy and Commerce Committee, has been working closely with ranking minority leader Rep. Frank Pallone (D-NJ) to secure bipartisan support for a half dozen health-related bills that will soon be schedule for House floor, debate, and passage.
Perhaps the most significant for patients are the provisions of H.R. 3561, The Patient Act, which reinforces existing regulations related to promoting transparency. More specifically, the bill would require hospitals to publish a consumer-friendly list of the standard charges for a total of 300 shoppable services. The list must include the price for each item and service, including any current payer-specific negotiated charges, the maximum and minimum negotiated prices, and the discounted price. If hospitals fail to comply, they would be subjected to a fine, and the government would publish a list of those hospitals violating the law.
Their bill would also apply price transparency rules to health insurance plans, including plans in the individual market, as well as the small and large group markets. In other words, insurers would be required to provide the public with pricing information on benefits and services, including the in-network rates, the maximum allowed amount, and the amount of cost sharing for each item or service. Price transparency requirements would also apply to clinical laboratory tests, Medicare Advantage plans, Medicare prescription drug plans, and pharmacy benefit managers (PBMs).
This legislation is a good start. A robust price transparency policy could deliver significant health care savings. Writing in Inquiry, the Journal of Health Care Organization, Provision and Financing, Professor Stephen Parente of the University of Minnesota estimates that transparency for hospital and insurance pricing could potentially achieve an annual savings pf $80.7 billion in 2025, resulting in a 6.9 percent reduction medical spending for all privately insured persons. Low-income Americans would enjoy the greatest benefit.
Under Section 302 of The Patient Act, the authors also touch on the anti-competitive payment structure that benefits hospitals over patients. The bill stipulates that Medicare (beneficiaries and federal taxpayers) would pay no more for physician-administered drugs delivered in a hospital setting than in a doctor’s office. This would help establish wider site neutrality in Medicare payment, which would, in turn, start to create a level playing field for serious market competition between giant hospital corporations and independent medical practices. And more competition, of course means lower costs.
All of this would save a lot of money in the healthcare sector. According to a recent study conducted on behalf of the Blue Cross Blue Shield Association, comprehensive Medicare site neutrality would yield a total savings of $471 billion over ten years, including a reduction of $117 billion in private health insurance premiums.
It could also achieve serious financial advantages for consumers on the ground. Writing in JAMA Network, a team of academicians recently examined comparative pricing for a set of shoppable medical procedures delivered by 1116 conventional hospitals and 156 physician-owned hospitals in the same geographic areas. They found that the physician-owned hospitals were able to deliver the same services at prices that were approximately one-third lower than conventional hospitals. A stunning performance.
But there is one big problem: Medicare patients today cannot take full advantage of physician owned hospitals, despite their superior record in providing high quality and cost- effective care. With the Affordable Care Act (ACA), Congress and the Obama administration restricted Medicare and Medicaid reimbursement for these innovative facilities; an anti-competitive measure that undercuts seniors access to high quality and specialized hospital care.
It is past time to reverse this costly and outdated policy. And Congress should build on its recent momentum to turbo-charge its health care price transparency agenda.
One big idea the House should consider to accelerate the impact of price transparency is a “shared savings” program. Simply put, if an insured patient with several options for a medical service chooses a low-cost option, the insurance company would share the savings from that choice, say 50/50, with the patient.
In short, the insurance company would give the patient a tax-free rebate, which he could, if he wished, deposit in a health savings account. Such a program would harness the economic incentives of both patients and health insurers in securing cost- effective care, while intensifying competition among medical professionals in delivering high quality care at competitive prices.
If their record so far is any indication, the 118th Congress is well on its way to making serious progress on health care reform. They deserve credit, and more importantly, they deserve our support. After all, there is still much more to be done.
Robert E. Moffit, PhD., is a Senior Fellow, and Mary McCloskey is a Research Assistant, in the Center for Health and Welfare Studies at The Heritage Foundation.
Morning Brew's take on an earlier congressional hearing about insulin prices.
This article was previously posted in the Following Pharma section header.
"Executives from top insulin makers Eli Lilly and Company, Novo Nordisk, and Sanofi testified alongside the three largest pharmacy benefit managers (PBMs)—CVS Health, Optum Rx, and Express Scripts—in a Senate Health, Education, Labor, and Pensions (HELP) Committee hearing Wednesday over the drug’s increasing prices.
The hearing provided few solutions on how to make insulin more affordable, as the pharma executives and PBMs blamed each other for the high drug prices, echoing arguments made in 2019 that brought the same companies in front of Congress.
“If somebody in the real world is watching this hearing, they have heard every single person from the drug companies and from the PBMs say, ‘We are working tirelessly to lower the cost of prescription drugs, just knocking our brains out.’ And yet, at the end of the day, 1.3 million Americans are rationing their insulin,” HELP Committee Chairman Sen. Bernie Sanders said in the hearing Wednesday.
The insulin makers argued that higher rebate demands from PBMs have pushed list prices up. Drug manufacturers give PBMs rebates in exchange for preferential placement on a health plan’s list of approved medications. For every $1 increase in rebates, the list price of a prescription drug goes up $1.17 on average, according to a 2020 study from the University of Southern California."
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.





















